NetraMark Holdings Current Ratio 2024-2025 | AINMF

NetraMark Holdings current ratio from 2024 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
NetraMark Holdings Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2025-06-30 $0.00B $0.00B 2.91
2025-03-31 $0.00B $0.00B 3.59
2024-12-31 $0.00B $0.00B 2.71
2024-09-30 $0.00B $0.00B 0.51
2024-06-30 $0.00B $0.00B 2.20
2024-03-31 $0.00B $0.00B 1.85
2023-12-31 $0.00B $0.00B 2.98
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.073B $0.001B
NetraMark Holdings Inc. develops artificial intelligence and machine learning solutions for the pharmaceutical industry principally in Canada. NetraMark Holdings Inc. is based in Toronto, Canada.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $48.395B 59.05
Tempus AI (TEM) United States $14.291B 0.00
Doximity (DOCS) United States $11.985B 53.33
Hims & Hers Health (HIMS) United States $9.884B 76.72
IRhythm Technologies (IRTC) United States $5.815B 0.00
Hinge Health (HNGE) United States $3.560B 0.00
Privia Health (PRVA) United States $3.071B 227.46
Heartflow (HTFL) United States $2.895B 0.00
Inspire Medical Systems (INSP) United States $2.406B 39.82
Enovis (ENOV) United States $1.800B 9.51
10x Genomics (TXG) United States $1.679B 0.00
Omnicell (OMCL) United States $1.642B 32.79
Clover Health Investments (CLOV) United States $1.520B 0.00
Schrodinger (SDGR) United States $1.455B 0.00
Azenta (AZTA) United States $1.400B 61.08
Phreesia (PHR) United States $1.358B 0.00
Claritev (CTEV) United States $1.071B 0.00
Evolent Health (EVH) United States $0.746B 0.00
Fulgent Genetics (FLGT) United States $0.697B 0.00
Butterfly Network (BFLY) United States $0.632B 0.00
Talkspace (TALK) United States $0.576B 114.67
Veradigm (MDRX) United States $0.520B 0.00
Zepp Health (ZEPP) Netherlands $0.505B 0.00
Standard BioTools (LAB) United States $0.438B 0.00
Carlsmed (CARL) United States $0.322B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.305B 0.00
TruBridge (TBRG) United States $0.290B 50.76
CapsoVision (CV) United States $0.226B 0.00
MDxHealth SA (MDXH) Belgium $0.223B 0.00
Outset Medical (OM) United States $0.223B 0.00
Health Catalyst (HCAT) United States $0.215B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.191B 0.00
KORU Medical Systems (KRMD) United States $0.186B 0.00
Nyxoah SA (NYXH) Belgium $0.170B 0.00
CareCloud (CCLD) United States $0.125B 5.67
EUDA Health Holdings (EUDA) Singapore $0.119B 0.00
American Well (AMWL) United States $0.074B 0.00
Pulmonx (LUNG) United States $0.069B 0.00
P3 Health Partners (PIII) United States $0.060B 0.00
HeartBeam (BEAT) United States $0.057B 0.00
111 (YI) China $0.038B 0.00
Evaxion - (EVAX) Denmark $0.036B 0.00
Precipio (PRPO) United States $0.033B 0.00
Lunai Bioworks (LNAI) United States $0.027B 0.00
Predictive Oncology (POAI) United States $0.027B 0.00
Zhongchao (ZCMD) China $0.018B 0.00
Healthcare Triangle (HCTI) United States $0.016B 0.00
Bullfrog AI Holdings (BFRG) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.009B 0.00
PROFUSA (PFSA) United States $0.008B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
Movano (MOVE) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.002B 0.00
MSP Recovery (MSPR) United States $0.001B 0.00